DIRS.INFO The most relevant business & tech news

☆ The surprising group of stocks outperforming into a possible recession
▼ + stars: | 2022-12-09 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Industrials have shown "surprising strength," even as recession fears mount, according to Yardeni Research. The S & P 500 's industrial stocks have on average fallen a little less than 6% so far this year. That puts them in the middle of the pack among the 11 S & P sectors, but still a notable outperformance relative to the S & P 500's loss of almost 17% in the same period. Industrials are expected to post the second best earnings growth of the 11 S & P 500 sectors in 2023, Yardeni said. Boeing will also help the sector, Yardeni said, as the company sees increased demand upon resolution of its MAX jet safety issues.

☆ 2023 will be the worst year for the global economy in 4 decades, Citi predicts. Here's how investors can protect their money and position for a rally later on.
▼ + stars: | 2022-12-09 | by ( Marley Jay | Lisa Kailai Han | ) www.businessinsider.com time to read: +4 min

Citi Global Wealth CIO, David Bailin CitiCiti Global Wealth says investors should be cautious ahead of an oncoming US recession. The firm says 2023 will be the weakest year for global economic growth in four decades. "It's highly unlikely that we've seen the lows" in stocks, Bailin said. Overall, Citi thinks that 2023 will be the worst year for the global economy in four decades. But Bailin emphasizes that investors shouldn't sell and go to cash because they'll cost themselves money in that eventual recovery.

☆ The Biotech Takeout Menu Gets Pricier
▼ + stars: | 2022-12-08 | by ( David Wainer | ) www.wsj.com time to read: 1 min

Biotech investors are aware that there is a limited pool of companies that could move the needle financially this decade. Biotech stocks don’t behave like havens in a volatile market. Many have been trading below the value of their cash reserves over the past year. But a subset of the sector, those best positioned to help fill big pharma’s looming sales holes, are outperforming their peers. Large-cap biopharma companies are facing a $200 billion patent cliff, with sales of key drugs losing patent protection in the next few years.

☆ JPMorgan upgrades this materials stock, says it can weather decrease in residential construction
▼ + stars: | 2022-12-08 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Expect Vulcan Materials to outperform as its value improves and its business is more shielded than competitors to cooling residential construction, according to JPMorgan. A driver of the upgrade was the fact that Huerta no longer sees the stock trading at a premium to competitor Martin Marietta Materials . while residential construction volumes are expected to fall between 10% and 15%. On the other hand, California would be harder hit — and is already seeing demand fall — from the chill in residential construction. Huerta kept Vulcan rivals Martin Marietta Materials and Summit Materials as overweight and Eagle Materials at a neutral rating.

☆ UBS says high quality outperforms in recessions — 10 such stocks on sale
▼ + stars: | 2022-12-08 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +2 min

Look to cheap high-quality stocks to manage recession risk in the new year, according to UBS. UBS highlighted several stocks in the S & P 1500 with market caps of more than $6 billion. Here are 10 of the stocks: One of the highest-quality stocks on the list is cosmetics retailer Ulta Beauty , in the 99.1 percentile. Like Ulta, Walmart also raised its guidance when it reported earnings last month . Construction supplier Fastenal is another high ranker for quality, in the 95th percentile.

TSMC's Arizona factory has sparked concerns in Taiwan, where semiconductor manufacturing is the backbone of the economy, about a "goodbye to Taiwan" trend among chip firms. "TSMC's research and development centre is in Taiwan, the complete supply chain is here," she said. "Taiwan has a complete supply chain, a complete system, and the backing of the government. Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), , as it is formally called, has repeatedly said that the bulk of its manufacturing will remain in Taiwan. It is also encouraging more foreign tech firms in the chip supply chain to invest in Taiwan.

☆ Microsoft to bring Call of Duty to Nintendo, Sony on the spot
▼ + stars: | 2022-12-07 | by ( ) www.reuters.com time to read: +2 min

TOKYO, Dec 7 (Reuters) - Microsoft (MSFT.O) has entered into a 10-year commitment to bring the gaming title "Call of Duty" to Nintendo (7974.T) platforms, the chief executive officer of Microsoft Gaming, Phil Spencer, said in a post on Twitter on Wednesday. The agreement will bring the popular first-person shooter series from Activision Blizzard (ATVI.O) to Nintendo game consoles for the first time. "I think this is an attempt by Microsoft to pressure Sony into signing a deal with Activision and to make it easier for Microsoft to finish and close the deal with Activision," said Serkan Toto, founder of the Kantan Games consultancy. Microsoft competes with Sony and Nintendo in the global video game industry, which saw strong growth in recent years with people spending more time at home because of the coronavirus pandemic. Shares in Nintendo closed up 0.3% after the Microsoft announcement, outperforming the Nikkei average's (.N225) 0.7% slide and Sony's 1.3% fall.

☆ Jim Cramer's Investing Club meeting Wednesday: China reopening, Danaher, Apple
▼ + stars: | 2022-12-07 | by ( Krystal Hur | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Buy and hold Estee Lauder China on Wednesday announced significant rollbacks of its stringent zero-Covid policy. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

☆ Tech wreckage catches up to Salesforce as cloud giant's valuation reaches parity to Microsoft's
▼ + stars: | 2022-12-06 | by ( Michael Santoli | ) www.cnbc.com time to read: +4 min

This is the daily notebook of Mike Santoli, CNBC's senior markets commentator, with ideas about trends, stocks and market statistics. This pattern will break at some point, so a run to the old lows or beyond can't be assumed. Big Tech has done nothing to distinguish itself in the October-November rally in terms of regaining leadership. History says the big overheated leadership group of one bull market usually is sidelined even after the next one starts. It happened to Meta and Alphabet, now finally Salesforce is valued in parity with Microsoft after 17 years of extreme priciness.

☆ Fund manager names two global retailers that are about to 'dominate'
▼ + stars: | 2022-12-05 | by ( Ganesh Rao | ) www.cnbc.com time to read: +3 min

London-listed retailers Frasers Group and Next are two clothing retailers that will "dominate" the sector during a recession, according to a veteran Schroders fund manager. Andrew Brough, who runs the Schroder UK Mid Cap Fund, said the two conservatively run companies are well placed to expand and take market share during a downturn through acquisitions. Shares of Frasers Group have risen by 30.6% over the past year, outperforming the FTSE 350 general retailers index, which has fallen by 29.3% over the same period. Frasers Group is Brough's largest holding, making up 6.7% of his fund. Brough, who's run his fund for 23 years, said he was more optimistic than others about the U.K.'s economy over the near term.

☆ Do Humans Owe Animals Equal Rights? Martha Nussbaum Thinks So.
▼ + stars: | 2022-12-05 | by ( David Marchese | ) www.nytimes.com time to read: +15 min

Photo illustration by Bráulio Amado Talk Do Humans Owe Animals Equal Rights? But does it then follow that we think of animals’ lives as being equal in value to humans’? That would lead to redoubling our efforts to make sure animals don’t perish in the future. Just think: Women are often raped, and that has been so all throughout human history. Now, as an incrementalist I want to be cautious here because I don’t think that predatory animals are doing anything wrong.

☆ Tesla sold 100,291 China-made vehicles in Nov -Xinhua
▼ + stars: | 2022-12-05 | by ( ) www.reuters.com time to read: +1 min

SHANGHAI, Dec 5 (Reuters) - Tesla Inc (TSLA.O) delivered 100,291 China-made electric vehicles (EVs) in November, the highest monthly sales since its Shanghai factory opened in late 2020, a Xinhua report said on Monday. The number marks a 40% increase from October and 89.7% more than a year earlier after the U.S. automaker ramped up output at the Shanghai plant, cut prices for the best-selling models and offered incentives to Chinese buyers. However, BYD (002594.SZ) led all brands in China's November EV sales at 229,942 electric cars including plug-in hybrids and pure electric vehicles, three times more than a year earlier and more than double Tesla's tally, China Passenger Car Association data shows. BYD was the top-selling car brand in China in the first four weeks of November, data from China Merchants Bank International shows, outperforming the Volkswagen brand in a reversal that highlights the pressure on legacy brands in the world's largest auto market. Reporting by Zhang Yan, Brenda Goh and Beijing Newsroom Editing by Alison Williams and David GoodmanOur Standards: The Thomson Reuters Trust Principles.

☆ Goldman Sachs says this biotech stock can double on treatment against childhood brain tumor
▼ + stars: | 2022-12-05 | by ( Sarah Min | ) www.cnbc.com time to read: +2 min

Investors looking for exposure to the biotechnology sector should consider buying Day One Biopharmaceuticals , a stock that can more than double from current levels, according to Goldman Sachs. Analyst Andrea Tan initiated coverage on the biotechnology stock with a buy rating, saying positive data in the first quarter on a possible treatment for childhood brain tumors could unlock a multibillion-dollar sales opportunity. Initial reads on tovorafenib, a treatment for pediatric low-grade glioma, have so far been promising, according to the note. Tovorafenib is under evaluation in a clinical trial called FIREFLY-1 for relapsed pLGG, with data expected in the first quarter of 2023. The analyst expects positive topline data from the trial could serve as a catalyst for the stock and "support a path to approval" for the therapy.

☆ Here are Monday's biggest analyst calls: Apple, Amazon, Tesla, Netflix, Coinbase, Costco, Etsy & more
▼ + stars: | 2022-12-05 | by ( Michael Bloom | ) www.cnbc.com time to read: +7 min

JPMorgan reiterates Apple as overweight JPMorgan said Apple's iPhone supply chain challenges appear to be moderating. JPMorgan reiterates Netflix as overweight JPMorgan said it sees a "heavily backend-weighted quarter" for Netflix. Morgan Stanley initiates Marriott as overweight Morgan Stanley said it likes how the hotel chain has transformed its business and that it sees a "further re-rating." Jefferies reiterates Amazon and Etsy as buy Jefferies said Amazon and Etsy will be winners this holiday shopping season. Morgan Stanley downgrades Silvergate to underweight from equal weight Morgan Stanley said in its downgrade of the crypto bank that it sees too many headwinds due to the FTX collapse. "

☆ Stocks are likely to get smacked down in the first half of 2023 before markets improve
▼ + stars: | 2022-12-05 | by ( Patti Domm | In | ) www.cnbc.com time to read: +5 min

The outlook for next year is a bit better for stocks, but the first half sounds like it could be downright ugly. The strategist expects lows to be retested due to what could be a significant decline in earnings as interest rates rise. Jeff Kleintop, Charles Schwab's chief global investment strategist, expects a shallow recession may already have begun. He predicts the first half will be worse for stocks than the back half of the year, with a choppiness similar to the past six months. Calvasina expects small caps to be an area of outperformance, and she still sees value in energy and financials.

☆ Top Wall Street analysts bet on these stocks to brace for a sharp downturn
▼ + stars: | 2022-12-04 | by ( Tipranks.Com Staff | ) www.cnbc.com time to read: +5 min

In this article ADIMCHPFANGVMW Follow your favorite stocks CREATE FREE ACCOUNTVMware at the NYSE, Dec. 14, 2021. Source: NYSEVMwareWhile software company VMware (VMW) reeled from lackluster quarterly results, Monness Crespi Hardt analyst Brian White maintained his positive conviction on the stock. Impressively, Hanold holds the 8th position among more than 8,000 analysts on TipRanks, and boasts a 70% success rate. Recently, Stifel analyst Tore Svanberg recently reiterated a buy rating on MCHP stock and even increased the price target to $80 from $77. (See Analog Devices Hedge Fund Trading Activity on TipRanks) The analyst sees Analog Devices outperforming its peers in the present challenging macroeconomic environment.

☆ Wall Street Week Ahead: Wall Street hunts for recession plays to weather potential 2023 turbulence
▼ + stars: | 2022-12-02 | by ( David Randall | ) www.reuters.com time to read: +5 min

JPMorgan, Citi and BlackRock are among those who believe a recession is likely in 2023. Nevertheless, many on Wall Street are increasing allocations to areas of the market that have a reputation for outperforming during uncertain economic times. The S&P 500 Health Care sector is down around 1.7% year-to-date, handily beating the broader index's performance. JPMorgan's analysts forecast a "mild recession" and expect the S&P 500 to test its 2022 lows in the first quarter of next year. Signs of ebbing inflation have fueled hopes that the Fed may tighten monetary policy less than expected, supporting a rebound in the S&P 500 that has buoyed the index from its October low.

☆ Goldman finds prior year's losers tend to beat the market in the first quarter — 10 laggard buys
▼ + stars: | 2022-12-02 | by ( Sarah Min | ) www.cnbc.com time to read: +3 min

As investors prepare their portfolios for the new year, Goldman Sachs revisited laggard stocks that have the potential to outperform at the start of 2023. In the past, stocks that lagged the broader market tended to become leaders in the first quarter of the following year, according to Goldman Sachs. Goldman Sachs searched for laggards across several different criteria. Another stock that made the list includes Adobe , which Goldman Sachs considers a buy-rated quality stock trading at a reasonable valuation. In October, Goldman Sachs analyst Kash Rangan identified the name as a tech stock that is resilient in a downturn .

☆ Here are Thursday's biggest analyst calls: Apple, Amazon, Tesla, Chipotle, Capital One, United & more
▼ + stars: | 2022-12-01 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

Morgan Stanley downgrades Capital One and Ally Financial to underweight from equal weight Morgan Stanley said in its downgrade of Capital One and Ally Financial that it sees "significant risk" for both stocks. Morgan Stanley reiterates Tesla as overweight Morgan Stanley said it's standing by it's overweight rating on Tesla but is concerned 2023 could be a disappointing year in general for electric vehicles. Morgan Stanley initiates Vizio as equal weight Morgan Stanley said it's concerned the television tech company lacks scale to keep up with bigger competitors. Morgan Stanley reiterates Salesforce as overweight Morgan Stanley said it's standing by shares of Salesforce after the company's disappointing earnings report on Wednesday. Morgan Stanley reiterates Snowflake as overweight Morgan Stanley said investors should stick with shares of Snowflake for the long-term after its earnings report on Wednesday.

☆ NASA's Orion capsule heads home on Artemis I moon mission
▼ + stars: | 2022-12-01 | by ( Jackie Wattles | ) edition.cnn.com time to read: +5 min

CNN —The NASA Orion spacecraft, the core of the Artemis I mission, is making a farewell pass by the moon on its historic journey before heading home to Earth. The Orion spacecraft is now expected to take another lap around the moon. That will mark the end of the historic Artemis I mission, which kicked off when the Orion spacecraft launched atop NASA’s new Space Launch System, or SLS, rocket on November 16. If the Artemis I mission is successful, NASA will then look to choose a crew to fly on the Artemis II mission, which could take off as soon as 2024. Read more: The big numbers that make the Artemis I moon mission a monumental feat‘Outstanding’ performanceThe spacecraft’s performance during this mission has been “outstanding,” Howard Hu, the Orion program manager, told reporters Monday evening.

☆ Cowen sees this airline stock continuing to separate itself from the pack, gaining nearly 50% in 2023
▼ + stars: | 2022-12-01 | by ( Sarah Min | ) www.cnbc.com time to read: +1 min

United Airlines is the airline stock to own in 2023, according to Cowen. "We are staying with United Airlines as our top pick for 2023. "The carrier's network and alliances position it to benefit from the recovery in international travel. "We are not anticipating a full recovery of business travel, but believe the hybrid work environment is likely to continue into 2023. Shares of United Airlines are up slightly in 2022.

☆ BYD set to be China's top-selling car brand for Nov, Tesla gains -data
▼ + stars: | 2022-11-30 | by ( ) www.reuters.com time to read: +3 min

REUTERS/Toya Sarno Jordan/File PhotoSHANGHAI, Nov 30 (Reuters) - BYD was the top-selling car brand in China in the first four weeks of November, brokerage data showed, outperforming the Volkswagen brand in a reversal that highlights the pressure on legacy brands in the world's largest auto market. Tesla's (TSLA.O) retail sales in China also nearly doubled in November, from a year earlier, after the U.S. automaker cut prices and offered incentives on its Model 3 and Model Y, the data from China Merchants Bank International (CMBI) showed. Retail sales for BYD totaled 152,863 vehicles from Nov. 1 to Nov. 27, logging a nearly 83% increase in average daily sales compared to the same period a year earlier, according to the data. BYD's tally was higher than Volkswagen's retail sales of 143,602 retail sales and Toyota Motor Corp's (7203.T) 115,272, which were 0.3% and 0.5% lower, respectively, on the year. However, the Volkswagen AG group still outsold BYD, when the 36,847 units sold under the Audi brand are included.

☆ Apple stock’s recent weakness could stem from safety-seeking investors who are now fleeing
▼ + stars: | 2022-11-29 | by ( Michael Santoli | ) www.cnbc.com time to read: +3 min

This is the daily notebook of Mike Santoli, CNBC's senior markets commentator, with ideas about trends, stocks and market statistics. We're not yet in breakdown mode, in other words, as the S & P 500 remains above its 20-day average (near 3,900). There's very much another value-over-growth tone: Month-to-date S & P 500 value is outperforming growth by three percentage points and by more than 20 so far this year. Breadth is positive despite the red S & P 500. VIX is hanging near 22, up off the low and very much in an inverse range to that of the S & P 500 for the past several months.

☆ Weakness in Apple’s stock could be a warning for the broader market, chart technicians say
▼ + stars: | 2022-11-29 | by ( Patti Domm | In | ) www.cnbc.com time to read: +4 min

Apple stock was down more than 2% Tuesday, after declining Monday and Friday. Apple's sizeable weighting Apple is 6.5% of the S & P 500 market cap, and technical analysts say it has implications for the broad market both in price impact and sentiment. Apple is 6.5% of the S & P. I would say it's remarkable how strong the S & P 500 is today with a 2% decline in Apple. "I can't imagine that happening without getting a sell signal on the S & P chart." She said the S & P 500 chart is maintaining a buy signal that has been in place for several weeks.

☆ India purchased 40% of seaborne Russian Urals oil in Nov. -Refinitiv data, traders
▼ + stars: | 2022-11-28 | by ( ) www.reuters.com time to read: +2 min

MOSCOW, Nov 28 (Reuters) - India bought about 40% of all Urals seaborne export volumes loading in November, outperforming other states as buyers, Reuters calculations based on Refinitiv and traders' data showed on Monday. Russian Urals oil shipments to India accounted for about 40% of the total sea exports of Urals in November, not including the transit of oil from Kazakhstan, which is sold as KEBCO, Reuters calculations showed. On Dec. 5, the European Union imposes an embargo on the supply of seaborne shipments of Russian oil. EU discussions of a price cap for the Russian oil is also complicating trade for December volumes, traders said, raising uncertainty. Turkey remains the main buyer of Urals in the Mediterranean, in November, deliveries to this country accounted for about 15% of all Urals sea exports, according to Reuters calculations.

Search resuls for: "outperforming"

25 mentions found